CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis

Cell Reports

Volumn 17, Issue 8, 2016, Pages 2004-2014

  Miyake, Kotaro ^a   Ohta, Toshio ^b   Nakayama, Hisako ^c   Doe, Nobutaka ^d   Terao, Yuri ^a   Oiki, Eiji ^a   Nagatomo, Izumi ^a   Yamashita, Yui ^e   Abe, Takaya ^e   Nishikura, Kazuko ^f   Kumanogoh, Atsushi ^a   Hashimoto, Kouichi ^c   Kawahara, Yukio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e RIKEN   (Japan)

^f WISTAR INSTITUTE   (United States)

Author keywords

ADAR; catecholamine; dense core vesicle; exocytosis; post transcriptional modification; syntaxin 1A

Indexed keywords

CALCIUM DEPENDENT ACTIVATOR PROTEIN FOR SECRETION 1; CATECHOLAMINE; CELL PROTEIN; RNA; SYNTAXIN 1A; UNCLASSIFIED DRUG; ADAR1 PROTEIN, MOUSE; ADAR2 PROTEIN, MOUSE; ADENOSINE DEAMINASE; CADPS PROTEIN, MOUSE; CALCIUM BINDING PROTEIN; MESSENGER RNA; NERVE PROTEIN; PROTEIN BINDING; RNA BINDING PROTEIN; SYNTAXIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL ANALYSIS; CATECHOLAMINE RELEASE; CELL ORGANELLE; CHROMAFFIN CELL; CONTROLLED STUDY; DENSE CORE VESICLE; ELECTROPHYSIOLOGY; EMBRYO; ENERGY EXPENDITURE; EXOCYTOSIS; GENE EXPRESSION; HYPERACTIVITY; MOUSE; MOUSE MUTANT; NERVE CELL; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; REGULATORY MECHANISM; RNA EDITING; UPREGULATION; ANIMAL; BIOCATALYSIS; BODY WEIGHT; CONFORMATION; ENERGY METABOLISM; GENETICS; MALE; METABOLISM; MUTANT MOUSE STRAIN; PC12 CELL LINE; RAT; SECRETORY VESICLE;

ADENOSINE DEAMINASE; ANIMALS; BIOCATALYSIS; BODY WEIGHT; CALCIUM-BINDING PROTEINS; CATECHOLAMINES; ENERGY METABOLISM; EXOCYTOSIS; MALE; MICE; MICE, MUTANT STRAINS; NERVE TISSUE PROTEINS; NUCLEIC ACID CONFORMATION; PC12 CELLS; PHYSICAL CONDITIONING, ANIMAL; PROTEIN BINDING; RATS; RNA EDITING; RNA, MESSENGER; RNA-BINDING PROTEINS; SECRETORY VESICLES; SYNTAXIN 1;

EID: 85004039883     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.10.073     Document Type: Article

References (45)

1. Athanasiadis, A., Rich, A., Maas, S., Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol., 2, 2004, e391.
2. Bailey, A., Hervas, A., Matthews, N., Palferman, S., Wallace, S., Aubin, A., Michelotti, J., Wainhouse, C., Papanikolaou, K., Rutter, M., International Molecular Genetic Study of Autism Consortium. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum. Mol. Genet. 7 (1998), 571–578.
3. V1.3 channels. Cell Rep. 5 (2013), 367–377.
4. Behm, M., Öhman, M., RNA editing: A contributor to neuronal dynamics in the mammalian brain. Trends Genet. 32 (2016), 165–175.
5. Bhalla, T., Rosenthal, J.J.C., Holmgren, M., Reenan, R., Control of human potassium channel inactivation by editing of a small mRNA hairpin. Nat. Struct. Mol. Biol. 11 (2004), 950–956.
6. Brusa, R., Zimmermann, F., Koh, D.S., Feldmeyer, D., Gass, P., Seeburg, P.H., Sprengel, R., Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270 (1995), 1677–1680.
7. Burns, C.M., Chu, H., Rueter, S.M., Hutchinson, L.K., Canton, H., Sanders-Bush, E., Emeson, R.B., Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387 (1997), 303–308.
8. Daniel, C., Wahlstedt, H., Ohlson, J., Björk, P., Öhman, M., Adenosine-to-inosine RNA editing affects trafficking of the gamma-aminobutyric acid type A (GABA(A)) receptor. J. Biol. Chem. 286 (2011), 2031–2040.
9. de la Hoz, A.B., Maortua, H., García-Rives, A., Martínez-González, M.J., Ezquerra, M., Tejada, M.-I., 3p14 de novo interstitial microdeletion in a patient with intellectual disability and autistic features with language impairment: A comparison with similar cases. Case Rep. Genet., 2015, 2015, 876348.
10. de Wit, H., Walter, A.M., Milosevic, I., Gulyás-Kovács, A., Riedel, D., Sørensen, J.B., Verhage, M., Synaptotagmin-1 docks secretory vesicles to syntaxin-1/SNAP-25 acceptor complexes. Cell 138 (2009), 935–946.
11. Eisenberg, E., Nemzer, S., Kinar, Y., Sorek, R., Rechavi, G., Levanon, E.Y., Is abundant A-to-I RNA editing primate-specific?. Trends Genet. 21 (2005), 77–81.
12. Farina, M., van de Bospoort, R., He, E., Persoon, C.M., van Weering, J.R., Broeke, J.H., Verhage, M., Toonen, R.F., CAPS-1 promotes fusion competence of stationary dense-core vesicles in presynaptic terminals of mammalian neurons. eLife, 4, 2015, e05438.
13. Gerber, A.P., Keller, W., RNA editing by base deamination: More enzymes, more targets, new mysteries. Trends Biochem. Sci. 26 (2001), 376–384.
14. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., Caron, M.G., Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996), 606–612.
15. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59 (1992), 848–856.
16. 2+-dependent exocytosis. J. Biol. Chem. 277 (2002), 22025–22034.
17. Hammarlund, M., Watanabe, S., Schuske, K., Jorgensen, E.M., CAPS and syntaxin dock dense core vesicles to the plasma membrane in neurons. J. Cell Biol. 180 (2008), 483–491.
18. Hartner, J.C., Schmittwolf, C., Kispert, A., Müller, A.M., Higuchi, M., Seeburg, P.H., Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J. Biol. Chem. 279 (2004), 4894–4902.
19. Higuchi, M., Maas, S., Single, F.N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R., Seeburg, P.H., Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406 (2000), 78–81.
20. Huntley, M.A., Lou, M., Goldstein, L.D., Lawrence, M., Dijkgraaf, G.J., Kaminker, J.S., Gentleman, R., Complex regulation of ADAR-mediated RNA-editing across tissues. BMC Genomics, 17, 2016, 61.
21. International Molecular Genetic Study of Autism Consortium (IMGSAC). Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum. Mol. Genet. 10 (2001), 973–982.
22. James, D.J., Kowalchyk, J., Daily, N., Petrie, M., Martin, T.F., CAPS drives trans-SNARE complex formation and membrane fusion through syntaxin interactions. Proc. Natl. Acad. Sci. USA 106 (2009), 17308–17313.
23. Jockusch, W.J., Speidel, D., Sigler, A., Sørensen, J.B., Varoqueaux, F., Rhee, J.-S., Brose, N., CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins. Cell 131 (2007), 796–808.
24. Kawahara, Y., Zinshteyn, B., Sethupathy, P., Iizasa, H., Hatzigeorgiou, A.G., Nishikura, K., Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315 (2007), 1137–1140.
25. Kawahara, Y., Zinshteyn, B., Chendrimada, T.P., Shiekhattar, R., Nishikura, K., RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep. 8 (2007), 763–769.
26. Kawahara, Y., Grimberg, A., Teegarden, S., Mombereau, C., Liu, S., Bale, T.L., Blendy, J.A., Nishikura, K., Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. J. Neurosci. 28 (2008), 12834–12844.
27. Li, J.B., Levanon, E.Y., Yoon, J.-K., Aach, J., Xie, B., Leproust, E., Zhang, K., Gao, Y., Church, G.M., Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 324 (2009), 1210–1213.
28. Liddicoat, B.J., Piskol, R., Chalk, A.M., Ramaswami, G., Higuchi, M., Hartner, J.C., Li, J.B., Seeburg, P.H., Walkley, C.R., RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349 (2015), 1115–1120.
29. Liu, Y., Schirra, C., Stevens, D.R., Matti, U., Speidel, D., Hof, D., Bruns, D., Brose, N., Rettig, J., CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles. J. Neurosci. 28 (2008), 5594–5601.
30. Morabito, M.V., Abbas, A.I., Hood, J.L., Kesterson, R.A., Jacobs, M.M., Kump, D.S., Hachey, D.L., Roth, B.L., Emeson, R.B., Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol. Dis. 39 (2010), 169–180.
31. Narboux-Nême, N., Sagné, C., Doly, S., Diaz, S.L., Martin, C.B., Angenard, G., Martres, M.-P., Giros, B., Hamon, M., Lanfumey, L., et al. Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: Neural and behavioral consequences. Neuropsychopharmacology 36 (2011), 2538–2550.
32. Nguyen Truong, C.Q., Nestvogel, D., Ratai, O., Schirra, C., Stevens, D.R., Brose, N., Rhee, J., Rettig, J., Secretory vesicle priming by CAPS is independent of its SNARE-binding MUN domain. Cell Rep. 9 (2014), 902–909.
33. 2+ channel beta3 subunit-null mice. Biochem. Biophys. Res. Commun. 394 (2010), 464–469.
34. Parsaud, L., Li, L., Jung, C.H., Park, S., Saw, N.M.N., Park, S., Kim, M.Y., Sugita, S., Calcium-dependent activator protein for secretion 1 (CAPS1) binds to syntaxin-1 in a distinct mode from Munc13-1. J. Biol. Chem. 288 (2013), 23050–23063.
35. Pinto, Y., Cohen, H.Y., Levanon, E.Y., Mammalian conserved ADAR targets comprise only a small fragment of the human editosome. Genome Biol., 15, 2014, R5.
36. Sadakata, T., Washida, M., Iwayama, Y., Shoji, S., Sato, Y., Ohkura, T., Katoh-Semba, R., Nakajima, M., Sekine, Y., Tanaka, M., et al. Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J. Clin. Invest. 117 (2007), 931–943.
37. Sakurai, M., Ueda, H., Yano, T., Okada, S., Terajima, H., Mitsuyama, T., Toyoda, A., Fujiyama, A., Kawabata, H., Suzuki, T., A biochemical landscape of A-to-I RNA editing in the human brain transcriptome. Genome Res. 24 (2014), 522–534.
38. 2+-dependent activator proteins for secretion: Comparative analysis of structure, expression, localization, and function. J. Biol. Chem. 278 (2003), 52802–52809.
39. Speidel, D., Bruederle, C.E., Enk, C., Voets, T., Varoqueaux, F., Reim, K., Becherer, U., Fornai, F., Ruggieri, S., Holighaus, Y., et al. CAPS1 regulates catecholamine loading of large dense-core vesicles. Neuron 46 (2005), 75–88.
40. Speidel, D., Salehi, A., Obermueller, S., Lundquist, I., Brose, N., Renström, E., Rorsman, P., CAPS1 and CAPS2 regulate stability and recruitment of insulin granules in mouse pancreatic β cells. Cell Metab. 7 (2008), 57–67.
41. Taniguchi, T., Doe, N., Matsuyama, S., Kitamura, Y., Mori, H., Saito, N., Tanaka, C., Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation. FEBS Lett. 579 (2005), 5704–5712.
42. Tomaselli, S., Locatelli, F., Gallo, A., The RNA editing enzymes ADARs: Mechanism of action and human disease. Cell Tissue Res. 356 (2014), 527–532.
43. Wang, Q., Khillan, J., Gadue, P., Nishikura, K., Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290 (2000), 1765–1768.
44. Wulff, B.-E., Sakurai, M., Nishikura, K., Elucidating the inosinome: Global approaches to adenosine-to-inosine RNA editing. Nat. Rev. Genet. 12 (2011), 81–85.
45. Yagi, T., Tokunaga, T., Furuta, Y., Nada, S., Yoshida, M., Tsukada, T., Saga, Y., Takeda, N., Ikawa, Y., Aizawa, S., A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214 (1993), 70–76.